ClinicalTrials.gg

Program

tu-100

Also written as “TU-100” and “Daikenchuto Extract Granules (TU-100)”.

Its studies are mostly in Ileus · Irritable Bowel Syndrome · Crohn Disease, led by Tsumura USA.

Furthest: phase 2, since Dec 14, 20055 company-led studies, 1 open or runningNext primary completion: Jun 2028 (phase 2)

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Tsumura USA51 open or runningphase 2since Dec 14, 2005Dec 14, 2005Jun 2028phase 2 · NCT07765589

Also a collaborator on its studies: icon-clinical-research.

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Dec 14, 2005First study: phase 2 study in Postoperative IleusFirst studyNCT00266461 · 24 enrolled · United States
  2. Jul 5, 2011Phase 2 study in Crohn DiseaseNCT01388933 · 79 enrolled · United States
  3. Feb 24, 2014Phase 2 study in Irritable Bowel SyndromeNCT02074579 · 101 enrolled · United States
  4. Jan 29, 2021Phase 2 study in Enhanced Recovery After SurgeryNCT04742907 · 402 enrolled · United States
  5. Aug 6, 2026Phase 2 study in Delay in GI Recovery/Postoperative Ileus (POI)NCT07765589 · 240 planned

Ahead

  1. Jun 2028Primary completion: phase 2 study in Delay in GI Recovery/Postoperative Ileus (POI)NCT07765589

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 5 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT07765589Delay in GI Recovery/Postoperative Ileus (POI)2Not yet recruitingJun 2028240
NCT04742907Enhanced Recovery After Surgery · United States2CompletedMar 25, 2024402
NCT02074579Irritable Bowel Syndrome · United States2CompletedApr 2016101
NCT01388933Crohn Disease · United States2TerminatedSep 201379
NCT00266461Postoperative Ileus · United States2CompletedJan 200824

How it is read

Names in the registry

  • “TU-100”, 4 entries
  • “Daikenchuto Extract Granules (TU-100)”, 1 entry

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.
tu-100 (Tsumura USA): development program | ClinicalTrials.gg